188 related articles for article (PubMed ID: 9206997)
1. Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy.
Kishi S; Saijyo S; Arai M; Karasawa S; Ueda S; Kannagi M; Iwakura Y; Fujii M; Yonehara S
J Exp Med; 1997 Jul; 186(1):57-64. PubMed ID: 9206997
[TBL] [Abstract][Full Text] [Related]
2. The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen.
Iwakura Y; Itagaki K; Ishitsuka C; Yamasaki Y; Matsuzawa A; Yonehara S; Karasawa S; Ueda S; Saijo S
J Immunol; 1998 Dec; 161(12):6592-8. PubMed ID: 9862686
[TBL] [Abstract][Full Text] [Related]
3. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.
Arai M; Kannagi M; Matsuoka M; Sato T; Yamamoto N; Fujii M
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):261-7. PubMed ID: 9491917
[TBL] [Abstract][Full Text] [Related]
4. Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein.
Zehender G; Varchetta S; De Maddalena C; Colasante C; Riva A; Meroni L; Moroni M; Galli M
Virology; 2001 Mar; 281(1):43-50. PubMed ID: 11222094
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease.
Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y
J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
Okamoto K; Fujisawa J; Reth M; Yonehara S
Genes Cells; 2006 Feb; 11(2):177-91. PubMed ID: 16436054
[TBL] [Abstract][Full Text] [Related]
7. Articular tissues expressing the env-pX transgene are required for generation of arthritogenic T cells in human T cell leukemia virus type I transgenic rats.
Abe A; Ishizu A; Fugo K; Ikeda H; Yoshiki T
Clin Exp Rheumatol; 2006; 24(3):313-6. PubMed ID: 16870101
[TBL] [Abstract][Full Text] [Related]
8. Evidence for autoantigens of Env/Tax proteins in human T cell leukemia virus type I Env-pX transgenic mice.
Fujisawa K; Okamoto K; Asahara H; Hasunuma T; Kobata T; Kato T; Sumida T; Nishioka K
Arthritis Rheum; 1998 Jan; 41(1):101-9. PubMed ID: 9433875
[TBL] [Abstract][Full Text] [Related]
9. Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene.
Kotani M; Tagawa Y; Iwakura Y
Eur J Immunol; 1999 Jan; 29(1):54-64. PubMed ID: 9933086
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.
Fujisawa K; Asahara H; Okamoto K; Aono H; Hasunuma T; Kobata T; Iwakura Y; Yonehara S; Sumida T; Nishioka K
J Clin Invest; 1996 Jul; 98(2):271-8. PubMed ID: 8755634
[TBL] [Abstract][Full Text] [Related]
11. Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction.
Cruz AC; Ramaswamy M; Ouyang C; Klebanoff CA; Sengupta P; Yamamoto TN; Meylan F; Thomas SK; Richoz N; Eil R; Price S; Casellas R; Rao VK; Lippincott-Schwartz J; Restifo NP; Siegel RM
Nat Commun; 2016 Dec; 7():13895. PubMed ID: 28008916
[TBL] [Abstract][Full Text] [Related]
12. [Pathomechanism of HTLV-I associated arthropathy and the role of tax gene].
Hasunuma T
Nihon Rinsho; 1997 Jun; 55(6):1482-5. PubMed ID: 9200936
[TBL] [Abstract][Full Text] [Related]
13. Models of HTLV-I-induced diseases. Infectious transmission of HTLV-I in inbred rats and HTVL-I env-pX transgenic rats.
Yoshiki T; Ikeda H; Tomaru U; Ohya O; Kasai T; Yamashita I; Morita K; Yamazaki H; Ishizu A; Nakamaru Y; Kikuchi K; Tanaka S; Wakisaka A
Leukemia; 1997 Apr; 11 Suppl 3():245-6. PubMed ID: 9209354
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of infiltrating T cells in the affected autoimmune lesions of HTLV-I transgenic rats].
Sugaya T
Hokkaido Igaku Zasshi; 2001 Jan; 76(1):35-47. PubMed ID: 11235211
[TBL] [Abstract][Full Text] [Related]
15. Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator.
Chen X; Zachar V; Zdravkovic M; Guo M; Ebbesen P; Liu X
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3277-85. PubMed ID: 9400978
[TBL] [Abstract][Full Text] [Related]
16. HTLV-I env-pX transgenic rats: prototype animal model for collagen vascular diseases.
Yamazaki H; Ikeda H; Ishuzu A; Shikishima H; Kikuchi K; Wakisaka A; Hatanaka M; Yoshiki T
Leukemia; 1997 Apr; 11 Suppl 3():258-9. PubMed ID: 9209358
[TBL] [Abstract][Full Text] [Related]
17. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
Datta A; Silverman L; Phipps AJ; Hiraragi H; Ratner L; Lairmore MD
Retrovirology; 2007 Jul; 4():49. PubMed ID: 17634129
[TBL] [Abstract][Full Text] [Related]
18. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I.
Yamazaki H; Ikeda H; Ishizu A; Nakamaru Y; Sugaya T; Kikuchi K; Yamada S; Wakisaka A; Kasai N; Koike T; Hatanaka M; Yoshiki T
Int Immunol; 1997 Feb; 9(2):339-46. PubMed ID: 9040015
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K
J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219
[TBL] [Abstract][Full Text] [Related]
20. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
Martínez-Lorenzo MJ; Alava MA; Gamen S; Kim KJ; Chuntharapai A; Piñeiro A; Naval J; Anel A
Eur J Immunol; 1998 Sep; 28(9):2714-25. PubMed ID: 9754559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
